<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">helmholtzeyeinstitute</journal-id><journal-title-group><journal-title xml:lang="ru">Российский офтальмологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Ophthalmological Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0076</issn><issn pub-type="epub">2587-5760</issn><publisher><publisher-name>Real time Publishers</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21516/2072-0076-2025-18-1-43-47</article-id><article-id custom-type="elpub" pub-id-type="custom">helmholtzeyeinstitute-1724</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Инфекционный статус пациентов с болезнью Коатса</article-title><trans-title-group xml:lang="en"><trans-title>The infectious status of patients with Coats disease</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1038-2746</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нероева</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Neroeva</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Нероева Наталия Владимировна — канд. мед. наук, руководитель отдела патологии сетчатки и зрительного нерва.</p><p>ул. Садовая-Черногрязская, д. 14/19, Москва, 105062</p></bio><bio xml:lang="en"><p>Natalia V. Neroeva — Cand. of Med. Sci., head of the department of pathology of the retina and optic nerve.</p><p>14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Танковский</surname><given-names>В. Э.</given-names></name><name name-style="western" xml:lang="en"><surname>Tankovskiy</surname><given-names>V. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Танковский Владимир Эдуардович — д-р мед. наук, старший научный сотрудник отдела патологии сетчатки и зрительного нерва, доцент кафедры непрерывного медицинского образования.</p><p>ул. Садовая-Черногрязская, д. 14/19, Москва, 105062</p></bio><bio xml:lang="en"><p>Vladimir E. Tankovskiy — Dr. of Med. Sci., senior researcher of the department of pathology of the retina and optic nerve, associate professor of chair of continuing medical education.</p><p>14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4608-0136</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пономарева</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Ponomareva</surname><given-names>S. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Пономарева Саина Иннокентьевна — клинический ординатор.</p><p>ул. Садовая-Черногрязская, д. 14/19, Москва, 105062</p></bio><bio xml:lang="en"><p>Saina I. Ponomareva — resident.</p><p>14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062</p></bio><email xlink:type="simple">sainaponomareva@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «НМИЦ глазных болезней им. Гельмгольца» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Helmholtz National Medical Research Center of Eye Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>27</day><month>03</month><year>2025</year></pub-date><volume>18</volume><issue>1</issue><fpage>43</fpage><lpage>47</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Нероева Н.В., Танковский В.Э., Пономарева С.И., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Нероева Н.В., Танковский В.Э., Пономарева С.И.</copyright-holder><copyright-holder xml:lang="en">Neroeva N.V., Tankovskiy V.E., Ponomareva S.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://roj.igb.ru/jour/article/view/1724">https://roj.igb.ru/jour/article/view/1724</self-uri><abstract><p>Цель работы — изучить распространенность различных хронических инфекций, частоту их реактивации и ассоциации микроорганизмов у пациентов с болезнью Коатса. Материал и методы. Проведен ретроспективный анализ медицинских карт 30 пациентов (36 глаз) в возрасте от 18 до 78 лет (в среднем 45,6 ± 15,8 года) с болезнью Коатса, находившихся на лечении в отделении патологии сетчатки и зрительного нерва НМИЦ ГБ им. Гельмгольца в период с 2008 по 2023 г. Для оценки инфекционного статуса больных методом иммуноферментного анализа (ИФА) на автоматическом ИФА-анализаторе «Лазурит» (США) с диагностическими тест-системами «Вектор-Бест» (Кольцово) определяли серологические маркеры офтальмотропных инфекций: антитела к герпес-вирусам — вирусу простого герпеса (ВПГ) 1-го типа (ВПГ 1), ВПГ 2-го типа (ВПГ 2), цитомегаловирусу (ЦМВ), вирусу Эпштейна — Барр (ВЭБ), а также к токсоплазме гондии, токсокаре канис, хламидии трахоматис, хламидофиле пневмонии, микоплазме гоминис, уреаплазме уреалитикум. Результаты. Наиболее часто у пациентов с болезнью Коатса выявлялись серологические маркеры реактивации ВПГ 1 (в 64,7%). У большинства пациентов отмечено микст-инфицирование с преобладанием 4 и более возбудителей офтальмотропных инфекций. Отмечается тенденция к преобладанию у мужчин маркеров реактивации ВПГ 1, а у женщин — ЦМВ. В ранние стадии заболевания реактивация вирусов группы герпеса (ВПГ 1, ВПГ 2, ЦМВ, ВЭБ) выявлена у 40% пациентов, а в поздние стадии — у 26,6%. Заключение. Особенности взаимодействия вируса с клетками хозяина, которые приводят к стимуляции синтеза VEGF-A по нескольким механизмам, в конечном итоге проявляются сосудистыми изменениями, которые характерны, возможно, и для болезни Коатса.</p></abstract><trans-abstract xml:lang="en"><p>Purpose of this work is to study the prevalence of various chronic infections, the frequency of their reactivation and associations of microorganisms in patients with Coats' disease. Material and methods. A retrospective analysis of medical records of 30 patients (36 eyes) aged from 18 to 78 years (mean 45.6 ± 15.8 years) with Coats' disease, who were treated in the Department of Retinal and Optic Nerve Pathology of the Helmholtz National Medical Research Center of Eye Diseases in the period from 2008 to 2023. To assess the infectious status of patients by the enzyme-linked immunosorbent assay (ELISA) method on the automatic ELISA analyzer "Lazurit" (USA) with the diagnostic test systems "Vector-Best" (Koltsovo) were determined serological markers of ophthalmotropic infections: antibodies to herpes viruses — herpes simplex virus (HSV) type 1 (HSV 1), HSV type 2 (HSV 2), cytomegalovirus (CMV), Epstein — Barr virus (EBV), as well as toxoplasma gondii, toxocara canis, chlamydia trachomatis, chlamydophila pneumoniae, mycoplasma hominis, ureaplasma urealyticum. Results. Serological markers of HSV 1 reactivation were most frequently detected in patients with Coats disease (64.7%). Most patients had mixed infection with a predominance of 4 or more ophthalmotropic infection pathogens. There is a tendency for markers of HSV type 1 reactivation to predominate in men and CMV in women. In the early stages of the disease, reactivation of herpes viruses (HSV 1, HSV 2, CMV, EBV) was detected in 40% of patients, and in the late stages in 26.6%. There are known features of the interaction of the virus with host cells, which lead to stimulation of VEGF-A synthesis by several mechanisms, which eventually manifests itself in the form of vascular abnormalities, which are characteristic, perhaps, of Coats disease. Conclusion. The features of the interaction of the virus with host cells, which lead to stimulation of VEGF-A synthesis by several mechanisms, ultimately manifest themselves in vascular changes, which are possibly characteristic of Coats disease.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Коатс</kwd><kwd>болезнь Коатса</kwd><kwd>сосудистые заболевания сетчатки</kwd><kwd>офтальмотропные инфекции</kwd><kwd>вирус простого герпеса</kwd><kwd>эндотелиальный фактор роста сосудов</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Coats</kwd><kwd>Coats disease</kwd><kwd>retinal vascular disease</kwd><kwd>eye infections</kwd><kwd>herpes simplex virus</kwd><kwd>vascular endothelial growth factor</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Shields JA, Shields CL, Honavar SG, Demirci H. Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture. Am J Ophthalmol. 2001; 131 (5): 561–71. doi: 10.1016/s0002-9394(00)00883-7</mixed-citation><mixed-citation xml:lang="en">Shields JA, Shields CL, Honavar SG, Demirci H. Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture. Am J Ophthalmol. 2001; 131 (5): 561–71. doi: 10.1016/s0002-9394(00)00883-7</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Morris B, Mulvihill A. A population-based study of Coats disease in the United Kingdom I: epidemiology and clinical features at diagnosis. Eye. 2010; 24: 1797–801. doi: 10.1038/eye.2010.126</mixed-citation><mixed-citation xml:lang="en">Morris B, Mulvihill A. A population-based study of Coats disease in the United Kingdom I: epidemiology and clinical features at diagnosis. Eye. 2010; 24: 1797–801. doi: 10.1038/eye.2010.126</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Coats G. Forms of retinal disease with massive exudation. Roy London Ophthalmol Hosp Rep. 1908; 17: 440–525.</mixed-citation><mixed-citation xml:lang="en">Coats G. Forms of retinal disease with massive exudation. Roy London Ophthalmol Hosp Rep. 1908; 17: 440–525.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Leber T. Verber ein durch yorkommen miltipler miliaraneurisi men characterisierte form von retinal-degeneration. Graefes Arch Clin Exp Ophthalmol. 1912; 81: 1–14.</mixed-citation><mixed-citation xml:lang="en">Leber T. Verber ein durch yorkommen miltipler miliaraneurisi men characterisierte form von retinal-degeneration. Graefes Arch Clin Exp Ophthalmol. 1912; 81: 1–14.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">François J, Rabaey M, Evens L, de Vos E. Etude histo-pathologique d'une rétinite de Coats probablement toxoplasmique [Histopathological study of a Coats retinitis probably toxoplasmic]. Bull Soc Belge Ophtalmol. 1956; 111: 448–63.</mixed-citation><mixed-citation xml:lang="en">François J, Rabaey M, Evens L, de Vos E. Etude histo-pathologique d'une rétinite de Coats probablement toxoplasmique [Histopathological study of a Coats retinitis probably toxoplasmic]. Bull Soc Belge Ophtalmol. 1956; 111: 448–63.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Frezzotti R, Berengo A, Guerra R, Cavallini F. Toxoplasmic Coats’ retinitis. A parasitologically proved case. Am J Ophthalmol. 1965 Jun; 59: 1099–102. PMID: 14292723.</mixed-citation><mixed-citation xml:lang="en">Frezzotti R, Berengo A, Guerra R, Cavallini F. Toxoplasmic Coats’ retinitis. A parasitologically proved case. Am J Ophthalmol. 1965 Jun; 59: 1099–102. PMID: 14292723.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Теплинская Л.Е., Калибердина А.Ф. Иммунопатогенетические, клинические особенности и лечение наружного экссудативного ретинита Коатса. Вестник офтальмологии. 2000; 116 (3): 28–31.</mixed-citation><mixed-citation xml:lang="en">Teplinskaya L.E., Kaliberdina A.F. Immunopathogenetic, clinical features and treatment of external exudative Coats' retinitis. Vestnik oftal’mologii. 2000;116 (3): 28–31 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ghassemi F, Sabour S. Coats disease and cytomegalovirus infection. Iran J Ophthalmol. 2012; 24 (2): 75–78. Available from: http://irjo.org/browse.php?a_id=669&amp;slc_lang=en&amp;sid=1&amp;ftxt=1</mixed-citation><mixed-citation xml:lang="en">Ghassemi F, Sabour S. Coats disease and cytomegalovirus infection. Iran J Ophthalmol. 2012; 24 (2): 75–78. Available from: http://irjo.org/browse.php?a_id=669&amp;slc_lang=en&amp;sid=1&amp;ftxt=1</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ghassemi F, Shields CL, Mohebbi M, et al. Serum hypercoagulability states in Coats’ disease. Clin Ophthalmol. 2017; 11: 305–10. https://doi.org/10.2147/OPTH.S121375</mixed-citation><mixed-citation xml:lang="en">Ghassemi F, Shields CL, Mohebbi M, et al. Serum hypercoagulability states in Coats’ disease. Clin Ophthalmol. 2017; 11: 305–10. https://doi.org/10.2147/OPTH.S121375</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Белозеров E.C., Буланьков Ю.И. Болезни герпес-вирусной группы. Элиста: АПП «Джангар»; 2005: 64.</mixed-citation><mixed-citation xml:lang="en">Belozerov EC, Bulan'kov JuI. Diseases of the herpesvirus group. Elista: APP Dzhangar; 2005: 64 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Дранник Г.Н. Клиническая иммунология и аллергология. Москва: Медицина; 2003.</mixed-citation><mixed-citation xml:lang="en">Drannik G.N. Klinicheskaja immunologija i allergologija. Moscow: Medicina; 2003 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Хрянин А.А., Решетников О.В., Кувшинова И.Н. Токсоплазмоз: эпидемиология, диагностика и лечение. Антибиотики и химиотерапия. 2015; 60 (5–6): 16–21. https://www.antibiotics-chemotherapy.ru/jour/article/view/600/600</mixed-citation><mixed-citation xml:lang="en">Hrjanin A.A., Reshetnikov O.V., Kuvshinova I.N. Toxoplasmosis: epidemiology, diagnosis and treatment. Antibiotiki i Khimioterapija. 2015; 60 (5–6): 16–21 (In Russ.). https://www.antibiotics-chemotherapy.ru/jour/article/view/600/600</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Fernandes BF, Odashiro AN, Maloney S, et al. Clinical-histopathological correlation in a case of Coats' disease. Diagn Pathol. 2006 Aug 30; 1: 24. doi: 10.1186/1746-1596-1-24</mixed-citation><mixed-citation xml:lang="en">Fernandes BF, Odashiro AN, Maloney S, et al. Clinical-histopathological correlation in a case of Coats' disease. Diagn Pathol. 2006 Aug 30; 1: 24. doi: 10.1186/1746-1596-1-24</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Lim WK, Nussenblatt RB, Chan CC. Immunopathologic features of inflammatory coats disease. Arch Ophthalmol. 2005; 123 (2): 279–81. doi: 10.1001/archopht.123.2.279</mixed-citation><mixed-citation xml:lang="en">Lim WK, Nussenblatt RB, Chan CC. Immunopathologic features of inflammatory coats disease. Arch Ophthalmol. 2005; 123 (2): 279–81. doi: 10.1001/archopht.123.2.279</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">He YG, Wang H, Zhao B, et al. Elevated vascular endothelial growth factor level in Coats' disease and possible therapeutic role of bevacizumab. Graefes Arch Clin Exp Ophthalmol. 2010; 248: 1519–21. doi: 10.1007/s00417-010-1366-1</mixed-citation><mixed-citation xml:lang="en">He YG, Wang H, Zhao B, et al. Elevated vascular endothelial growth factor level in Coats' disease and possible therapeutic role of bevacizumab. Graefes Arch Clin Exp Ophthalmol. 2010; 248: 1519–21. doi: 10.1007/s00417-010-1366-1</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Biswas P., Banerjee K., Kinchington P. Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Experimental Eye Research. 2006; 82 (1): 46–54. doi.org/10.1016/j.exer.2005.05.001</mixed-citation><mixed-citation xml:lang="en">Biswas P., Banerjee K., Kinchington P. Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Experimental Eye Research. 2006; 82 (1): 46–54. doi.org/10.1016/j.exer.2005.05.001</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Wuest T, Zheng M, Efstathiou S, Halford WP, Carr DJ. The herpes simplex virus-1 transactivator infected cell protein-4 drives VEGF-A dependent neovascularization. PLoS Pathogens. 2011; 7(10):e1002278. doi: 10.1371/journal.ppat.1002278</mixed-citation><mixed-citation xml:lang="en">Wuest T, Zheng M, Efstathiou S, Halford WP, Carr DJ. The herpes simplex virus-1 transactivator infected cell protein-4 drives VEGF-A dependent neovascularization. PLoS Pathogens. 2011; 7(10):e1002278. doi: 10.1371/journal.ppat.1002278</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Suryawanshi A, Mulik S, Sharma S, et al. Ocular neovascularization caused by herpes simplex virus type 1 infection results from breakdown of binding between vascular endothelial growth factor A and its soluble receptor. J Immunol. 2011; 186: 3653–65. doi: 10.4049/jimmunol.1003239</mixed-citation><mixed-citation xml:lang="en">Suryawanshi A, Mulik S, Sharma S, et al. Ocular neovascularization caused by herpes simplex virus type 1 infection results from breakdown of binding between vascular endothelial growth factor A and its soluble receptor. J Immunol. 2011; 186: 3653–65. doi: 10.4049/jimmunol.1003239</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Suryawanshi A, Veiga-Parga T, Reddy PB, et al. IL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infection. J Immunol. 2012 Apr 1; 188 (7): 3434–46. doi: 10.4049/jimmunol.1102602</mixed-citation><mixed-citation xml:lang="en">Suryawanshi A, Veiga-Parga T, Reddy PB, et al. IL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infection. J Immunol. 2012 Apr 1; 188 (7): 3434–46. doi: 10.4049/jimmunol.1102602</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Mulik S, Xu J, Reddy P, et al. Role of miR-132 in angiogenesis after ocular infection with herpes simplex virus. Am J Pathol. 2012; 181 (2): 525–34. doi: 10.1016/j.ajpath.2012.04.014</mixed-citation><mixed-citation xml:lang="en">Mulik S, Xu J, Reddy P, et al. Role of miR-132 in angiogenesis after ocular infection with herpes simplex virus. Am J Pathol. 2012; 181 (2): 525–34. doi: 10.1016/j.ajpath.2012.04.014</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Gurung H, Carr M, Bryant K, et al. Fibroblast growth factor-2 drives and maintains progressive corneal neovascularization following HSV-1 infection. Mucosal Immunol. 2018; 11 (1): 172–85. doi: 10.1038/mi.2017.26</mixed-citation><mixed-citation xml:lang="en">Gurung H, Carr M, Bryant K, et al. Fibroblast growth factor-2 drives and maintains progressive corneal neovascularization following HSV-1 infection. Mucosal Immunol. 2018; 11 (1): 172–85. doi: 10.1038/mi.2017.26</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Vinores S, Derevjanik N, Shi A, et al. Vascular endothelial growth factor (VEGF), transforming growth factor-beta (TGFbeta), and interleukin-6 (IL-6) in experimental herpes virus retinopathy: association with inflammation and viral infection. Histol Histopathol. 2001; 16 (4): 1061–71. doi: 10.14670/HH-16.1061</mixed-citation><mixed-citation xml:lang="en">Vinores S, Derevjanik N, Shi A, et al. Vascular endothelial growth factor (VEGF), transforming growth factor-beta (TGFbeta), and interleukin-6 (IL-6) in experimental herpes virus retinopathy: association with inflammation and viral infection. Histol Histopathol. 2001; 16 (4): 1061–71. doi: 10.14670/HH-16.1061</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
